IL10RA and pancreatic ductal adenocarcinoma: Our results validate improved IL-10RA and IDO expression in human pancreatic ductal adenocarcinoma (PDAC) tumours (Fig. 6a,, b), and reveal their robust correlation (Fig. 6c).